Haemonetics Corp (NYSE:HAE)

69.43
Delayed Data
As of Sep 24
 -0.20 / -0.29%
Today’s Change
49.26
Today|||52-Week Range
142.11
-41.53%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 77.50, with a high estimate of 90.00 and a low estimate of 68.00. The median estimate represents a +11.62% increase from the last price of 69.43.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Haemonetics Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.61
Sales
$240.9M
Reporting Date
Nov 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 21.16%
 
 
 
 
 
 
Growthannually 17.65%
 
 
 
 
 
 

Sales

Growthquarterly 5.40%
 
 
 
 
 
 
Growthannually 16.46%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.